原发性和继发性免疫缺陷病中的白细胞迁移抑制因子（LMIF）概况
Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.
作者信息
Górski A J, Dupont B, Hansen J A, O'Reilly R, Smithwick E, Górska R, Good R A
出版信息
Clin Exp Immunol. 1976 Dec;26(3):505-10.
Abstract
Lymphocytes from patients with primary and secondary immunodeficiency disease were tested for capacity to produce LMIF after mitogen and antigen stimulation as well as for ability to stimulate and respond in unidirectional MLC-LMIF assay. Different patterns of immune abnormality in vitro were detectable when Con A and Candida albicans antigen were used. In addition, significant abnormalities in LMIF responding and stimulatory capacity were demonstrated in patients with Hodgkin's disease. LMIF production after stimulation with different agents allows for a better characterization of cellular defects in immunodeficiency disease.
摘要
对原发性和继发性免疫缺陷病患者的淋巴细胞进行检测，以观察其在有丝分裂原和抗原刺激后产生淋巴细胞移动抑制因子（LMIF）的能力，以及在单向混合淋巴细胞培养-淋巴细胞移动抑制因子（MLC-LMIF）试验中的刺激和反应能力。当使用刀豆蛋白A（Con A）和白色念珠菌抗原时，可检测到体外不同模式的免疫异常。此外，霍奇金病患者在淋巴细胞移动抑制因子反应和刺激能力方面存在显著异常。用不同试剂刺激后产生淋巴细胞移动抑制因子，有助于更好地鉴定免疫缺陷病中的细胞缺陷。
相似文献
1
Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.原发性和继发性免疫缺陷病中的白细胞迁移抑制因子（LMIF）概况
Clin Exp Immunol. 1976 Dec;26(3):505-10.
2
3
Leukocyte migration inhibitory factor (LMIF) production in unidirectional mixed lymphocyte cultures.单向混合淋巴细胞培养中白细胞迁移抑制因子（LMIF）的产生
J Immunol. 1976 Sep;117(3):865-70.
4
5
Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.伴刀豆球蛋白A诱导的白细胞迁移抑制因子（LMIF）：体外产生的标准化微量测定法。
Proc Natl Acad Sci U S A. 1975 Aug;72(8):3197-200. doi: 10.1073/pnas.72.8.3197.
6
Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.用人胸腺淋巴细胞特异性抗血清描绘的人T细胞异质性。对丝裂原反应、混合淋巴细胞培养、细胞介导的淋巴细胞毒性和淋巴因子产生的体外影响。
J Clin Invest. 1975 May;55(5):956-66. doi: 10.1172/JCI108025.
7
In vitro assay for responsiveness of lymphocytes to transfer factor by a new leukocyte migration inhibitory test.通过一种新的白细胞迁移抑制试验对淋巴细胞对转移因子的反应性进行体外测定。
Microbiol Immunol. 1978;22(11):701-10. doi: 10.1111/j.1348-0421.1978.tb00423.x.
8
Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.慢性化脓性鼻窦炎患者对共生微生物的T细胞介导免疫参数：迟发型超敏皮肤试验、淋巴细胞转化试验和巨噬细胞移动抑制因子测定之间的比较
Clin Exp Immunol. 1986 Dec;66(3):516-24.
9
10
Use of transfer factor in patients with depressed cellular immunity and chronic infection.转移因子在细胞免疫功能低下及慢性感染患者中的应用。
Birth Defects Orig Artic Ser. 1975;11(1):431-5.
引用本文的文献
1
The effect of uraemic "middle-sized molecules" on T lymphocyte functions.尿毒症“中分子物质”对T淋巴细胞功能的影响。
Int Urol Nephrol. 1980;12(4):367-74. doi: 10.1007/BF02082475.
2
Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency.在重症联合免疫缺陷变异型患者中联合使用胎儿肝脏和胸腺进行免疫重建的理论依据。
Proc Natl Acad Sci U S A. 1977 Jul;74(7):3002-5. doi: 10.1073/pnas.74.7.3002.
本文引用的文献
1
Studies on mediator production by highly purified human T and B lymphocytes.关于高纯度人T淋巴细胞和B淋巴细胞产生介质的研究。
J Exp Med. 1974 Nov 1;140(5):1303-16. doi: 10.1084/jem.140.5.1303.
2
Malignant disease of the lymphoid system in immunological perspective.从免疫学角度看淋巴系统恶性疾病。
Hum Pathol. 1974 Sep;5(5):567-99. doi: 10.1016/s0046-8177(74)80007-9.
3
Immunologic impairment in patients with non-lymphoid cancer: correlation with the tumoral stage, response to treatment and survival.非淋巴细胞癌患者的免疫功能损害：与肿瘤分期、治疗反应及生存的相关性
Cancer. 1976 Feb;37(2):724-8. doi: 10.1002/1097-0142(197602)37:2<724::aid-cncr2820370219>3.0.co;2-g.
4
Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.伴刀豆球蛋白A诱导的白细胞迁移抑制因子（LMIF）：体外产生的标准化微量测定法。
Proc Natl Acad Sci U S A. 1975 Aug;72(8):3197-200. doi: 10.1073/pnas.72.8.3197.
5
6
Suppressor thymus-derived lymphocytes in fungal infection.真菌感染中胸腺来源的抑制性淋巴细胞
J Clin Invest. 1976 Feb;57(2):319-28. doi: 10.1172/JCI108283.
7
Lymphocyte abnormalities in untreated patients with Hodgkin's disease.未经治疗的霍奇金病患者的淋巴细胞异常。
Cancer. 1976 Feb;37(2):751-62. doi: 10.1002/1097-0142(197602)37:2<751::aid-cncr2820370223>3.0.co;2-2.
8
Separation of T cell subpopulations capable of DNA synthesis, lymphotoxin release, and regulation of antigen and phytohemagglutinin responses on the basis of density and adherence properties.根据密度和黏附特性分离能够进行DNA合成、释放淋巴毒素以及调节对抗原和植物血凝素反应的T细胞亚群。
Proc Natl Acad Sci U S A. 1975 Dec;72(12):5090-4. doi: 10.1073/pnas.72.12.5090.
9
Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.PHA刺激的淋巴细胞产生白细胞抑制因子（LIF）和巨噬细胞抑制因子（MIF）。
Clin Exp Immunol. 1975 Dec;22(3):522-7.
10
Cellular immunity in neoplasia. Antigen and mitogen responses in patients with bronchiogenic carcinoma.肿瘤中的细胞免疫。支气管源性癌患者的抗原和丝裂原反应。
Cancer. 1975 Dec;36(6):2010-5. doi: 10.1002/cncr.2820360913.
Zotero 插件